Cardiac intensive care management of high-risk percutaneous coronary intervention using the venoarterial ECMO support.
Marco ZuinGianluca RigatelliRamesh DaggubatiPublished in: Heart failure reviews (2021)
The emerging concept of high-risk percutaneous coronary intervention (HR-PCI) has required the adoption of a multidisciplinary team approach. Venoarterial ECMO (VA-ECMO) has been introduced as a temporary mechanical circulatory support (MCS) for HR-PCI patients in order to provide an adequate systemic perfusion during the procedure. Both patient's complexity and technological evolutions have catalyzed the development of critical care cardiology; however, ECMO therapy faces several challenges. Indeed, the management of patients on ECMO remains complex; moreover, the lack of specific recommendation for HR-PCI patients further complicates the management of these patients. In this narrative review, we give a reappraisal for the management of HR-PCI patients supported with VA-ECMO according to the available data published in current literature.
Keyphrases
- extracorporeal membrane oxygenation
- percutaneous coronary intervention
- end stage renal disease
- acute respiratory distress syndrome
- chronic kidney disease
- coronary artery disease
- newly diagnosed
- acute coronary syndrome
- acute myocardial infarction
- ejection fraction
- prognostic factors
- st elevation myocardial infarction
- peritoneal dialysis
- stem cells
- systematic review
- magnetic resonance
- left ventricular
- patient reported outcomes
- intensive care unit
- bone marrow
- case report
- mesenchymal stem cells